Silo Pharma, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €62.09K +0.0% -€3.78M +18.7% -6,092.6% -9.6 pp -€3.30M +18.9% -5,317.3% -8.5 pp
    €62.09K +0.0% -€3.19M -5.3% -5,132.6% +2.9 pp -€2.78M -7.8% -4,472.1% +3.8 pp
    €62.09K +1.2% -€3.37M -200.1% -5,420.9% -110 pp -€3.01M +53.5% -4,850.9% -17 pp
    €61.37K +74.1% €3.36M -224.7% 5,477.9% +130 pp -€1.96M +96.9% -3,196.6% -3.7 pp
    €35.24K +0.9% -€2.70M +198.6% -7,648.2% -51 pp -€996.38K +45.7% -2,827.3% -8.7 pp
    €34.94K +∞% -€902.59K +8.1% -2,583.5% -26 pp -€684.05K -391.3% -1,958.0% -20 pp
    €0.00 -100.0% -€834.88K -371.9% N/A €234.79K -195.8% N/A
    €729.77K -226.6% €307.04K -132.0% 42.1% -1.2 pp -€245.11K +98.3% -33.6% -0.55 pp
    -€576.54K +361.1% -€958.47K +171.8% 166.2% -1.2 pp -€123.63K -85.9% 21.4% -6.8 pp
    -€125.03K +35.5% -€352.65K +8.8% 282.1% -0.69 pp -€875.61K -4.3% 700.3% -2.9 pp
    -€92.24K -201.5% -€324.28K -1,244.1% 351.5% +3.2 pp -€915.40K +485.3% 992.4% +12 pp
    €90.87K +∞% €28.34K -183.4% 31.2% +0.31 pp -€156.40K +745.8% -172.1% -1.7 pp
    €0.00 +NaN% -€33.97K -20.8% N/A -€18.49K -53.6% N/A
    €0.00 -€42.89K N/A -€39.88K N/A

    Notifications